Innovation Tiger 2025, a partnering event with over 7 global pharmaceutical companies and VC firms, will be held Calling for challengers from Asian startups and academia
Press Release
May 23, 2025
iPark Institute Co., Ltd.
Innovation Tiger 2025, a partnering event with over 7 global pharmaceutical companies and VC firms, will be held
Calling for challengers from Asian startups and academia
● Applications open on May 23rd. 10 to 15 outstanding teams will be selected.
● Selected finalists will pitch at Innovation Tiger 2025, held on September 30, the top five teams will receive prize money.
● Finalists will be mentored for approximately two months by experts with deep experience in the pharmaceutical industry.
● The selection committee (tiger) comprises more than seven big pharma and VCs, providing startups and academia with the opportunity to receive feedback from experts in the field.
● Finalists will also gain access to the Shonan Health Innovation Conference (SHIC 2025) in Boston this November.
Aiming to promote and advance health innovation from Asia, iPark Institute Co., Ltd. (Head office: Fujisawa City, Kanagawa Prefecture; CEO: Toshio Fujimoto; hereinafter referred to as “iPark Institute”) will hold the Innovation Tiger 2025 event for startups with promising Asian drug discovery and academia with excellent seeds and potential. It is partnered with Japan-based global pharmaceutical companies and venture capitalists (hereinafter referred to as “VC”) participating as the selection committee (tiger).
Innovation Tiger Recruitment Guidelines
Shonan iPark Website – Innovation Tiger Overview Page >Entry Form
Mentoring for Finalists
Experts such as business development staff from pharmaceutical companies and former pharmaceutical company employees will mentor the finalists for about two months. This includes business plans, presentation materials, and pitch preparations for the Innovation Tiger event on September 30th and the SHIC 2025 event in Boston in November.
Overview of Innovation Tiger Event
Shonan iPark Website – Innovation Tiger Overview Page >Details
Selection Committee (Tiger)
Applications for promising seeds from startups and academia open on May 23rd and iPark Institute will select 10-15 finalists who will receive mentoring for about two months before pitching their ideas at Innovation Tiger 2025 on September 30th at Shonan iPark. On the day, global pharmaceutical companies and VCs will serve as the selection committee, and the top five finalists will receive prize money and the right to participate in SHIC 2025 in Boston in November.
About iPark Institute Co., Ltd.
iPark Institute Co., Ltd. was established in 2023 with Industrial & Infrastructure Fund Investment Corporation (IIF), Takeda Pharmaceutical Company Limited (Takeda), and Mitsubishi Corporation as major shareholders. It took over the management of Shonan Health Innovation Park (Fujisawa City, Kanagawa Prefecture) in 2023, which Takeda has been responsible for since 2018. For more information about our company, please click here.
About Shonan Health Innovation Park (Shonan iPark)
Shonan iPark is Japan’s first pharmaceutical-initiated science park, created by Takeda Pharmaceutical Company Limited in April 2018 by opening its own research laboratories to the outside world. Currently operated by iPark Institute Co., Ltd. independent of Takeda Pharmaceutical Company Limited, the park aims to become a place where industry, government, and academia from a wide range of industries and sizes can come together to accelerate health innovation. Currently, the ecosystem is comprised of not only pharmaceutical companies, but also companies and organizations in nextgeneration medicine, cellular agriculture, AI, and government, with approximately 190 companies and more than 2,500 people (as of May 2025).
Click here for homepage
For the latest information on tenants and member companies at Shonan iPark, click here.
Official social links: YouTube / Facebook / X (former Twitter) / LinkedIn
For inquiries regarding this matter, please contact:
iPark Institute Co., Ltd., Communications
Attn: Sugita, Tsukahara
Mail: iPi.PR@shonan-ipark.com